PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Cardiovascular Medicine (M.K., H.A.C., O.V., K.T., J.R., J.E.F.), University of Massachusetts Medical School, Worcester, MA.\', \'Department of Biochemistry and Molecular Pharmacology (M.S.), University of Massachusetts Medical School, Worcester, MA.\', \'Department of Medicine, Division of Infectious Disease and Immunology Department of Medicine (P.L., S.S., J.P.W., R.W.F.), University of Massachusetts Medical School, Worcester, MA.\', \'Heart, Vascular and Thoracic Institute (R.B., S.J.C.).\', \'Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, OH (R.B., M.G., S.J.C.).\', \'Diabetes Center of Excellence (K.M.P., A.C., R.M.), University of Massachusetts Medical School, Worcester, MA.\', \'Program in Molecular Medicine (K.M.P., R.M.), University of Massachusetts Medical School, Worcester, MA.\', \'Case Western Reserve University Lerner College of Medicine, Cleveland, OH (S.J.C.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/CIRCRESAHA.121.319117
?:hasPublicationType
?:journal
  • Circulation research
is ?:pmid of
?:pmid
?:pmid
  • 34293929
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.813
?:rankingScore_hIndex
  • 297
?:title
  • SARS-CoV-2 Initiates Programmed Cell Death in Platelets.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all